Heart Test Laboratories, Inc.

NasdaqCM HSCS

Heart Test Laboratories, Inc. Market Capitalization on January 14, 2025: USD 3.20 M

Heart Test Laboratories, Inc. Market Capitalization is USD 3.20 M on January 14, 2025, a -63.36% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Heart Test Laboratories, Inc. 52-week high Market Capitalization is USD 14.24 M on March 05, 2024, which is 345.20% above the current Market Capitalization.
Heart Test Laboratories, Inc. 52-week low Market Capitalization is USD 2.27 M on September 10, 2024, which is -29.14% below the current Market Capitalization.
Heart Test Laboratories, Inc. average Market Capitalization for the last 52 weeks is USD 5.48 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

NasdaqCM: HSCS

Heart Test Laboratories, Inc.

CEO	Mr. Andrew Simpson
IPO Date	June 16, 2022
Location	United States
Headquarters	550 Reserve Street
Employees	15
Sector	Health Care
Industries Medical Instruments Telehealth

Description

Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Key trends

Past 5 years